AnaptysBio Inc (ANAB) Q2 Revenue Beats Estimates; Price-to-Sales Ratio Signals High Growth Expectations

gurufocus.com · 2026-09-21

On September 21, 2026, AnaptysBio Inc (NASDAQ: ANAB) reported second-quarter revenue of $27.5 million, surpassing analyst expectations of $20.12 million. The co

Read the full story at gurufocus.com →